Shuchi Gulati

3.6k total citations
56 papers, 570 citations indexed

About

Shuchi Gulati is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Shuchi Gulati has authored 56 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 27 papers in Oncology and 19 papers in Molecular Biology. Recurrent topics in Shuchi Gulati's work include Renal cell carcinoma treatment (18 papers), Renal and related cancers (15 papers) and Cancer Genomics and Diagnostics (12 papers). Shuchi Gulati is often cited by papers focused on Renal cell carcinoma treatment (18 papers), Renal and related cancers (15 papers) and Cancer Genomics and Diagnostics (12 papers). Shuchi Gulati collaborates with scholars based in United States, Canada and India. Shuchi Gulati's co-authors include Deepak Gupta, H.K. Chuttani, Ulka N. Vaishampayan, Anthony A. Donato, Trisha M. Wise‐Draper, Vinita Takiar, Nicholas J. Vogelzang, Sarah Palackdharry, Mark H. Eckman and Maria Lehn and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Shuchi Gulati

51 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuchi Gulati United States 14 195 177 155 87 81 56 570
Kyaw Zin Thein United States 14 383 2.0× 220 1.2× 190 1.2× 114 1.3× 88 1.1× 91 920
İdris Yücel Türkiye 13 294 1.5× 101 0.6× 122 0.8× 74 0.9× 131 1.6× 43 716
Ishwori Dhakal United States 19 266 1.4× 111 0.6× 297 1.9× 38 0.4× 174 2.1× 41 894
Tzeon‐Jye Chiou Taiwan 17 254 1.3× 88 0.5× 245 1.6× 26 0.3× 45 0.6× 66 958
Abe E. Sahmoun United States 16 227 1.2× 237 1.3× 159 1.0× 161 1.9× 142 1.8× 48 1.1k
Keisuke Nakanishi Japan 17 132 0.7× 153 0.9× 261 1.7× 19 0.2× 134 1.7× 79 887
Necip Pirinçci Türkiye 13 85 0.4× 115 0.6× 120 0.8× 90 1.0× 50 0.6× 52 527
Xian‐Zhi Xiong China 15 118 0.6× 252 1.4× 117 0.8× 34 0.4× 40 0.5× 31 832
Dejan Radenković Serbia 13 240 1.2× 143 0.8× 74 0.5× 38 0.4× 75 0.9× 49 624
Henrik Lajer Denmark 16 237 1.2× 129 0.7× 197 1.3× 123 1.4× 177 2.2× 27 986

Countries citing papers authored by Shuchi Gulati

Since Specialization
Citations

This map shows the geographic impact of Shuchi Gulati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuchi Gulati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuchi Gulati more than expected).

Fields of papers citing papers by Shuchi Gulati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuchi Gulati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuchi Gulati. The network helps show where Shuchi Gulati may publish in the future.

Co-authorship network of co-authors of Shuchi Gulati

This figure shows the co-authorship network connecting the top 25 collaborators of Shuchi Gulati. A scholar is included among the top collaborators of Shuchi Gulati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuchi Gulati. Shuchi Gulati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gulati, Shuchi & William J. Murphy. (2025). Defining obesity in the context of cancer: thinking beyond body mass index. Trends in cancer. 11(5). 441–447.
2.
Gulati, Shuchi, Simpa S. Salami, Thenappan Chandrasekar, et al.. (2024). Differences in mutations across tumour sizes in clear‐cell renal cell carcinoma. British Journal of Urology. 135(2). 269–278. 1 indexed citations
3.
Barata, Pedro C., Shuchi Gulati, Andrew Elliott, et al.. (2024). Renal cell carcinoma histologic subtypes exhibit distinct transcriptional profiles. Journal of Clinical Investigation. 134(11). 8 indexed citations
4.
Gulati, Shuchi & Primo N. Lara. (2024). Belzutifan versus Everolimus in Advanced Kidney Cancer: A Commentary on LITESPARK-005 Trial from ESMO 2023. PubMed. 8(1). 23–24. 4 indexed citations
5.
Mar, Nataliya, Kevin Zarrabi, Shuchi Gulati, et al.. (2023). Therapy With Metronomic Cyclophosphamide (mCyc) for Previously-Treated Metastatic Castrate-Resistant Prostate Cancer (mCRPC). Clinical Genitourinary Cancer. 22(2). 217–223.
6.
Gulati, Shuchi, Vinita Takiar, Maria Lehn, et al.. (2023). Durvalumab plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: An Open-label, Nonrandomized, Phase II Clinical Trial. Clinical Cancer Research. 29(10). 1906–1915. 18 indexed citations
7.
Grivas, Petros, Srikala S. Sridhar, Begoña P. Valderrama, et al.. (2023). 2374P A phase Ib single-arm trial of bintrafusp alfa (BA) for pretreated, locally advanced/unresectable or metastatic (advanced) urothelial cancer (aUC). Annals of Oncology. 34. S1209–S1210. 2 indexed citations
8.
Tripathi, Abhishek, Catherine M. Tangen, Xiaochen Li, et al.. (2023). Pathologic concordance rate and outcomes by histologic subtype in advanced papillary renal cell (pRCC) carcinoma: An analysis from the SWOG S1500 (PAPMET) trial.. Journal of Clinical Oncology. 41(16_suppl). 4562–4562.
9.
Gulati, Shuchi & Mark H. Eckman. (2022). Anticoagulant Therapy for Cancer-Associated Thrombosis. Annals of Internal Medicine. 176(1). 1–9. 14 indexed citations
10.
11.
Gulati, Shuchi & Nicholas J. Vogelzang. (2021). Biomarkers in renal cell carcinoma: Are we there yet?. Asian journal of urology. 8(4). 362–375. 18 indexed citations
12.
Luginbuhl, Adam, David I. Kutler, Chad Zender, et al.. (2021). Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck Cancer. Frontiers in Oncology. 11. 786216–786216. 6 indexed citations
13.
Rao, Arpit, Joanne Xiu, Shuchi Gulati, et al.. (2021). Characterization of microsatellite instability (dMMR/MSI-H) and mutational landscape in a large contemporary cohort of upper tract urothelial cancer (UTUC) patients.. Journal of Clinical Oncology. 39(6_suppl). 465–465. 5 indexed citations
14.
McGregor, Bradley A., Daniel M. Geynisman, Mauricio Burotto, et al.. (2021). Efficacy outcomes of nivolumab + cabozantinib versus pembrolizumab + axitinib in patients with advanced renal cell carcinoma (aRCC): Matching-adjusted indirect comparison (MAIC).. Journal of Clinical Oncology. 39(15_suppl). 4578–4578. 2 indexed citations
15.
Gulati, Shuchi & Ulka N. Vaishampayan. (2020). Current State of Systemic Therapies for Advanced Renal Cell Carcinoma. Current Oncology Reports. 22(3). 26–26. 41 indexed citations
16.
Gulati, Shuchi, Ramya Muddasani, Paulo Gustavo Bergerot, & Sumanta K. Pal. (2020). Systemic therapy and COVID19: Immunotherapy and chemotherapy. Urologic Oncology Seminars and Original Investigations. 39(4). 213–220. 5 indexed citations
17.
Gulati, Shuchi, Sarah Palackdharry, John C. Morris, et al.. (2019). Phase 1 dose‐finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer. Cancer. 126(2). 354–362. 37 indexed citations
18.
Gulati, Shuchi, Sarah Palackdharry, Vinita Takiar, et al.. (2018). A phase I dose-finding study of metformin in combination with concurrent cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma.. Journal of Clinical Oncology. 36(15_suppl). 6074–6074. 1 indexed citations
19.
Gulati, Shuchi, et al.. (2015). Diabetes insipidus: An unusual presentation of adenocarcinoma of the lung in a patient with no identifiable lung mass. North American Journal of Medical Sciences. 7(10). 476–476. 2 indexed citations
20.
Gulati, Shuchi & Anthony A. Donato. (2012). Lupus anticoagulant and ANCA associated thrombotic vasculopathy due to cocaine contaminated with levamisole: a case report and review of the literature. Journal of Thrombosis and Thrombolysis. 34(1). 7–10. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyaw Zin Thein Breakdown of academic impact, for papers by İdris Yücel Breakdown of academic impact, for papers by Ishwori Dhakal Breakdown of academic impact, for papers by Tzeon‐Jye Chiou Breakdown of academic impact, for papers by Abe E. Sahmoun Breakdown of academic impact, for papers by Keisuke Nakanishi Breakdown of academic impact, for papers by Necip Pirinçci Breakdown of academic impact, for papers by Xian‐Zhi Xiong Breakdown of academic impact, for papers by Dejan Radenković Breakdown of academic impact, for papers by Henrik Lajer
Rankless by CCL
2026